Page last updated: 2024-11-11

broussonin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

broussonin B: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5315503
CHEMBL ID463454
SCHEMBL ID6822049
MeSH IDM0490825

Synonyms (13)

Synonym
broussonin b
CHEMBL463454
4-[3-(4-hydroxyphenyl)propyl]-3-methoxyphenol
bdbm50380997
SCHEMBL6822049
CJJJQWAYMRTLJT-UHFFFAOYSA-N
73731-86-9
AKOS032948864
FS-9269
B0005-458170
GLXC-18487
4-3-(4-ydroxyphenyl)ropyl]-3-ethoxyphenol
broussoninb
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pancreatic triacylglycerol lipaseSus scrofa (pig)IC50 (µMol)75.40000.00401.10246.5000AID657041
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1633142Inhibition of chymotrypsin-like activity of rat liver 26 proteasome assessed as decrease in fluorescence using succinyl-Leu-Leu-Val-Tyr-4-methylcoumaryl-7-amide as substrate preincubated for 30 mins followed by addition of substrate and measured after 1 h2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID657041Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate preincubated for 15 mins prior substrate addition measured after 15 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Apr-15, Volume: 22, Issue:8
A new pancreatic lipase inhibitor from Broussonetia kanzinoki.
AID657043Antiadipogenic activity in mouse 3T3L1 cells assessed as cell differentiation measuring inhibition of fat accumulation at 100 uM after 8 days by oil red O-staining based spectrophotometry relative to control2012Bioorganic & medicinal chemistry letters, Apr-15, Volume: 22, Issue:8
A new pancreatic lipase inhibitor from Broussonetia kanzinoki.
AID357965Inhibition of aromatase from human placental microsomes2001Journal of natural products, Oct, Volume: 64, Issue:10
Aromatase inhibitors from Broussonetia papyrifera.
AID657039Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate at 100 uM preincubated for 15 mins prior substrate addition measured after 15 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Apr-15, Volume: 22, Issue:8
A new pancreatic lipase inhibitor from Broussonetia kanzinoki.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]